Scott Hayton

Scott is the acting COO and head of strategy, managing the overall strategic direction of Quotient and ensuring execution on the day-to-day operations of the company. Scott is also an operating principal with Flagship Pioneering, where he specializes in turning fledgling innovative ideas into the next great life sciences company. 

Prior to joining Flagship in 2022, Scott spent nearly a decade as a strategy consultant with McKinsey & Company, where he helped biopharma companies wrestle with large strategic questions. During that time, he led McKinsey’s neuroscience practice and spent a 1‑year secondment at GatesVentures, the private office of Bill Gates, where he helped formulate his initial Alzheimer’s disease strategy. 

Scott holds a PhD in Neuroscience from Queen’s University and completed a postdoctoral fellowship at Stanford University, where he worked with Robert Malenka and Thomas Sudhof (2013 Nobel Laureate).